| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.046 | 0.1 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.092 | 0.1 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.049 | 0.1 |